Genentech, Inc.
512 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) (NCT03275103) | Genentech, Inc. | 2017-09-19 |
Track Genentech, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.